Trusynth Plus Neo

Features of Trusynth Plus Neo

Triclosan coating – approved by WHO for SSI’s (Surgical Site Infections) management
Triclosan is effective against broad spectrum of pathogens including S. aureus, MRSA, E. coli
Triclosan – well-established safety profile
Substantial persistent antimicrobial activity due to its residual effect
Good knot security and easy knot placement

Applications
Technical Details
Range

For soft tissue approximation
Mucosal closures
Skin closure
Dental surgery
Orthopedic surgery

The advanced braiding technology, smooth texture and Triclosan coating help avoid SSI. Trusynth Plus Neo is not recommended for use in cardiovascular and neurological tissues. This suture retains 60% of its initial tensile strength after 14 days and is absorbed by hydrolysis within 56 – 70 days of implantation.

Braided and coated polyglactin 910, coated with antibacterial agent Triclosan
Coating of calcium stearate and polyglactin 310
Available in undyed and violet colors
Sterilized by ethylene oxide
Shelf life of 5 years

USP sizes available : 4-0 to 2
Length available with needle: 35 cm to 185 cm
Needle length: 20 mm to 40 mm across all needle point profiles

Trusynth Plus Neo

Trusynth Plus Neo

Features of Trusynth Plus Neo

More Products

Truloop

Theruptor™ NXT

Trucath – 2 way

Trucath – 3 Way

CliniEupore

Truflon CVC